| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 522.922.672 $ | +321.874.011 $ | +389,0 % | 12 | 216.514.223 $ | +69.398.324 $ | +451,0 % | 7 | 192.984.726 $ | +105.649.735 $ | +209,2 % | 6 | ||||
| Scholar Rock Holding Corp | SRRK | → 0 | Neutral | 102.985.966 $ | +63.433.579 $ | +160,4 % | 1 | 39.552.387 $ | +12.484.630 $ | +46,1 % | 1 | 27.067.757 $ | +8.361.924 $ | +44,7 % | 1 |
| Abivax S.A. | ABVX | → 0 | Sehr schwach | 69.881.256 $ | +17.047.360 $ | +32,3 % | 1 | 52.833.896 $ | +38.717.318 $ | +274,3 % | 1 | ||||
| Roivant Sciences Ltd. | ROIV | → 0 | Schwach | 21.373.320 $ | +395.973 $ | +1,9 % | 1 | 20.977.347 $ | -42.526.092 $ | -67,0 % | 1 | 63.503.439 $ | +56.103.742 $ | +758,2 % | 1 |
| Syndax Pharmaceuticals Inc | SNDX | → 0 | Neutral | 56.979.512 $ | +28.839.159 $ | +102,5 % | 1 | 28.140.353 $ | +7.066.289 $ | +33,5 % | 1 | 21.074.064 $ | -1.145.653 $ | -5,2 % | 1 |
| Revolution Medicines, Inc. | RVMD | → 0 | Neutral | 55.827.424 $ | +50.886.575 $ | +1.029,9 % | 1 | ||||||||
| Immunovant, Inc. | IMVT | → 0 | Neutral | 37.595.822 $ | +21.200.964 $ | +129,3 % | 1 | 25.674.030 $ | +4.550.270 $ | +21,5 % | 1 | ||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Schwach | 36.257.330 $ | +30.048.042 $ | +483,9 % | 1 | ||||||||
| uniQure N.V. | QURE | → 0 | Schwach | 30.478.187 $ | +22.495.934 $ | +281,8 % | 1 | ||||||||
| MBX Biosciences, Inc. | MBX | → 0 | Neutral | 29.818.300 $ | +27.340.738 $ | +1.103,5 % | 1 | ||||||||
| Mineralys Therapeutics, Inc. | MLYS | → 0 | Neutral | 28.898.420 $ | +18.372.542 $ | +174,5 % | 1 | ||||||||
| Centessa Pharmaceuticals plc | CNTA | → 0 | 28.890.641 $ | +12.091.930 $ | +72,0 % | 1 | |||||||||
| Enliven Therapeutics, Inc. | ELVN | → 0 | Neutral | 28.493.540 $ | +28.493.540 $ | 1 | |||||||||
| CG Oncology, Inc. | CGON | → 0 | Neutral | 27.832.994 $ | +25.294.589 $ | +996,5 % | 1 | ||||||||
| Biohaven Ltd. | BHVN | → 0 | Schwach | 26.978.788 $ | +10.520.950 $ | +63,9 % | 1 | ||||||||
| Denali Therapeutics Inc. | DNLI | → 0 | Stark | 25.187.249 $ | +15.283.518 $ | +154,3 % | 1 | ||||||||
| Structure Therapeutics Inc. | GPCR | → 0 | Neutral | 24.417.127 $ | +20.795.747 $ | +574,2 % | 1 | ||||||||
| Arcellx, Inc. | ACLX | → 0 | 21.702.472 $ | +20.768.502 $ | +2.223,7 % | 1 | |||||||||
| 522.922.672 $ | +321.874.011 $ | +389,0 % | 12 | 216.514.223 $ | +69.398.324 $ | +451,0 % | 7 | 192.984.726 $ | +105.649.735 $ | +209,2 % | 6 | ||||